title: Minimal-change nephrotic syndrome associated with mixed connective-tissue disease.
authors.forename: T
authors.initials: T
authors.lastname: Uzu
authors.forename: H
authors.initials: H
authors.lastname: Iwatani
authors.forename: M
authors.initials: M
authors.lastname: Ko
authors.forename: M
authors.initials: M
authors.lastname: Yamato
authors.forename: K
authors.initials: K
authors.lastname: Takahara
authors.forename: A
authors.initials: A
authors.lastname: Yamauchi
mesh_terms: D000328:Adult; D000959:Antihypertensive Agents / Q000627:therapeutic use; D044466:Asian People; D005260:Female; D006801:Humans; D006976:Hypertension, Pulmonary / Q000150:complications / Q000188:drug therapy; D007564:Japan; D007678:Kidney Glomerulus / Q000473:pathology; D008775:Methylprednisolone / Q000627:therapeutic use; D008947:Mixed Connective Tissue Disease / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D009404:Nephrotic Syndrome / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D011241:Prednisone / Q000627:therapeutic use; D011928:Raynaud Disease / Q000150:complications
chemical_list: D000959:Antihypertensive Agents; D011241:Prednisone; D008775:Methylprednisolone